Literature DB >> 19211022

The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63).

Ali Badiee1, Mahmoud R Jaafari, Ali Khamesipour, Afshin Samiei, Dina Soroush, Masoumeh Tavassoti Kheiri, Farzaneh Barkhordari, W Robert McMaster, Fereidoun Mahboudi.   

Abstract

Liposomes as a lipid-based system have been shown to be an effective adjuvant formulation. In this study, the role of liposome charge in induction of a Th1 type of immune response and protection against leishmaniasis in BALB/c mice was studied. Liposomes containing rgp63 were prepared by Dehydration-Rehydration Vesicle (DRV) method. Neutral liposomes consisted of dipalmitoylphosphatidylcholine and cholesterol. Positively and negatively charged liposomes were prepared by adding dimethyldioctadecylammonium bromide (DDAB) or dicetyl phosphate (DCP) to the neutral liposome formulation, respectively. Female BALB/c mice were immunized subcutaneously with negatively, positively charged or neutral liposomes encapsulated with rgp63, rgp63 in soluble form or PBS, three times in 3week intervals. The extent of protection and type of immune response generated were studied in different groups of mice. The group of mice immunized with rgp63 encapsulated in neutral liposomes showed a significantly (P<0.01) smaller footpad swelling upon challenge with Leishmania major compared with positively or negatively charged liposomes. The mice immunized with neutral liposomes also showed a significantly (P<0.01) the lowest splenic parasite burden, the highest IgG2a/IgG1 ratio and IFN-gamma production and the lowest IL-4 level compared to the other groups. The results indicated that a Th1 type of immune response was induced in mice immunized with neutral liposomes more efficiently than positively charged liposomes and conversely negatively charged liposomes induced a Th2 type of immune response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211022     DOI: 10.1016/j.exppara.2008.12.015

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  11 in total

Review 1.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

2.  Negatively charged liposomes show potent adjuvant activity when simply admixed with protein antigens.

Authors:  Nijaporn Yanasarn; Brian R Sloat; Zhengrong Cui
Journal:  Mol Pharm       Date:  2011-06-07       Impact factor: 4.939

Review 3.  Liposomal adjuvant development for leishmaniasis vaccines.

Authors:  Anis Askarizadeh; Mahmoud Reza Jaafari; Ali Khamesipour; Ali Badiee
Journal:  Ther Adv Vaccines       Date:  2017-11-15

4.  Adjuvants for Leishmania vaccines: from models to clinical application.

Authors:  Vanitha S Raman; Malcolm S Duthie; Christopher B Fox; Greg Matlashewski; Steven G Reed
Journal:  Front Immunol       Date:  2012-06-11       Impact factor: 7.561

Review 5.  Liposomes as nanomedical devices.

Authors:  Giuseppina Bozzuto; Agnese Molinari
Journal:  Int J Nanomedicine       Date:  2015-02-02

6.  Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB/c mice.

Authors:  Ahmad Mehravaran; Maryam Rezaei Nasab; Hadi Mirahmadi; Iraj Sharifi; Ebrahim Alijani; Amin Reza Nikpoor; Javad Akhtari; Mansure Hojatizade
Journal:  Iran J Basic Med Sci       Date:  2019-08       Impact factor: 2.699

7.  Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model.

Authors:  Ensieh Golali; Mahmoud Reza Jaafari; Ali Khamesipour; Azam Abbasi; Zahra Saberi; Ali Badiee
Journal:  Iran J Basic Med Sci       Date:  2012-09       Impact factor: 2.699

Review 8.  Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators.

Authors:  Signe Tandrup Schmidt; Camilla Foged; Karen Smith Korsholm; Thomas Rades; Dennis Christensen
Journal:  Pharmaceutics       Date:  2016-03-10       Impact factor: 6.321

Review 9.  The Use of Synthetic Carriers in Malaria Vaccine Design.

Authors:  Liam Powles; Sue D Xiang; Cordelia Selomulya; Magdalena Plebanski
Journal:  Vaccines (Basel)       Date:  2015-10-29

10.  Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine.

Authors:  Natt Tasaniyananda; Urai Chaisri; Anchalee Tungtrongchitr; Wanpen Chaicumpa; Nitat Sookrung
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.